These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26203666)

  • 1. Human stromal cells are required for an anti-breast cancer effect of zoledronic acid.
    Nienhuis HH; Arjaans M; Timmer-Bosscha H; de Vries EG; Schröder CP
    Oncotarget; 2015 Sep; 6(27):24436-47. PubMed ID: 26203666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cells.
    Jiang P; Zhang P; Mukthavaram R; Nomura N; Pingle SC; Teng D; Chien S; Guo F; Kesari S
    Oncotarget; 2016 Sep; 7(36):57932-57942. PubMed ID: 27462771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid impairs re-epithelialization through down-regulation of integrin αvβ6 and transforming growth factor beta signalling in a three-dimensional in vitro wound healing model.
    Saito T; Izumi K; Shiomi A; Uenoyama A; Ohnuki H; Kato H; Terada M; Nozawa-Inoue K; Kawano Y; Takagi R; Maeda T
    Int J Oral Maxillofac Surg; 2014 Mar; 43(3):373-80. PubMed ID: 24021731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R; Sourla A; Lembessis P; Koutsilieris M
    Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway.
    Wilson C; Ottewell P; Coleman RE; Holen I
    BMC Cancer; 2015 Feb; 15():55. PubMed ID: 25884855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
    Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.
    Chiovaro F; Martina E; Bottos A; Scherberich A; Hynes NE; Chiquet-Ehrismann R
    Int J Cancer; 2015 Oct; 137(8):1842-54. PubMed ID: 25868708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma.
    Nakamura R; Kayamori K; Oue E; Sakamoto K; Harada K; Yamaguchi A
    Biochem Biophys Res Commun; 2015 Mar; 458(4):777-82. PubMed ID: 25681764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells.
    Oh HS; Moharita A; Potian JG; Whitehead IP; Livingston JC; Castro TA; Patel PS; Rameshwar P
    Cancer Res; 2004 Sep; 64(17):6327-36. PubMed ID: 15342422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
    Jagdev SP; Coleman RE; Shipman CM; Rostami-H A; Croucher PI
    Br J Cancer; 2001 Apr; 84(8):1126-34. PubMed ID: 11308265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone microenvironment-related growth factors, zoledronic acid and dexamethasone differentially modulate PTHrP expression in PC-3 prostate cancer cells.
    Tenta R; Sourla A; Lembessis P; Luu-The V; Koutsilieris M
    Horm Metab Res; 2005 Oct; 37(10):593-601. PubMed ID: 16278781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
    Lau CP; Huang L; Wong KC; Kumta SM
    Connect Tissue Res; 2013; 54(6):439-49. PubMed ID: 24060052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors.
    Kopecka J; Porto S; Lusa S; Gazzano E; Salzano G; Pinzòn-Daza ML; Giordano A; Desiderio V; Ghigo D; De Rosa G; Caraglia M; Riganti C
    Oncotarget; 2016 Apr; 7(15):20753-72. PubMed ID: 26980746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts.
    Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
    J Oral Pathol Med; 2014 Oct; 43(9):711-21. PubMed ID: 24762323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid-induced cytotoxicity through endoplasmic reticulum stress triggered REDD1-mTOR pathway in breast cancer cells.
    Lan YC; Chang CL; Sung MT; Yin PH; Hsu CC; Wang KC; Lee HC; Tseng LM; Chi CW
    Anticancer Res; 2013 Sep; 33(9):3807-14. PubMed ID: 24023313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment.
    Corso A; Ferretti E; Lazzarino M
    Hematology; 2005 Jun; 10(3):215-24. PubMed ID: 16019470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
    Sengupta S; Jana S; Bhattacharyya A
    Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.
    Ottewell PD; Lefley DV; Cross SS; Evans CA; Coleman RE; Holen I
    Int J Cancer; 2010 Jan; 126(2):522-32. PubMed ID: 19621384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.